These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11679423)

  • 1. Autoantibody response to islet transplantation in type 1 diabetes.
    Bosi E; Braghi S; Maffi P; Scirpoli M; Bertuzzi F; Pozza G; Secchi A; Bonifacio E
    Diabetes; 2001 Nov; 50(11):2464-71. PubMed ID: 11679423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
    Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
    J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes.
    Braghi S; Bonifacio E; Secchi A; Di Carlo V; Pozza G; Bosi E
    Diabetes; 2000 Feb; 49(2):218-24. PubMed ID: 10868938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet cell antibodies and glutamic acid decarboxylase antibodies in patients with insulin-dependent diabetes mellitus undergoing kidney and islet-after-kidney transplantation.
    Jaeger C; Hering BJ; Dyrberg T; Federlin K; Bretzel RG
    Transplantation; 1996 Aug; 62(3):424-6. PubMed ID: 8779696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts.
    Jaeger C; Brendel MD; Hering BJ; Eckhard M; Bretzel RG
    Diabetes; 1997 Nov; 46(11):1907-10. PubMed ID: 9356046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IA-2 antibodies are only positive in association with GAD 65 and islet cell antibodies in islet transplanted insulin-dependent diabetes mellitus patients.
    Jaeger C; Brendel MD; Hering BJ; Eckhard M; Federlin K; Bretzel RG
    Transplant Proc; 1998 Mar; 30(2):659-60. PubMed ID: 9532222
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics of diabetes-associated autoantibodies after sequential intraportal islet allograft associated with kidney transplantation in type 1 diabetes.
    Vantyghem MC; Fajardy I; Pigny P; Noel C; Kerr-Conte J; Gmyr V; Vandewalle B; Proye C; Pattou F
    Diabetes Metab; 2003 Dec; 29(6):595-601. PubMed ID: 14707888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of type 1 diabetes in patients receiving human fetal pancreatic tissue transplants without immunosuppression.
    Brooks-Worrell BM; Peterson KP; Peterson CM; Palmer JP; Jovanovic L
    Transplantation; 2000 May; 69(9):1824-9. PubMed ID: 10830218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.
    Keymeulen B; Ling Z; Gorus FK; Delvaux G; Bouwens L; Grupping A; Hendrieckx C; Pipeleers-Marichal M; Van Schravendijk C; Salmela K; Pipeleers DG
    Diabetologia; 1998 Apr; 41(4):452-9. PubMed ID: 9562350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients.
    van Kampen CA; van de Linde P; Duinkerken G; van Schip JJ; Roelen DL; Keymeulen B; Pipeleers DG; Claas FH; Roep BO
    Transplantation; 2005 Jul; 80(1):118-26. PubMed ID: 16003242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of type 1 diabetes in patients receiving human fetal pancreatic tissue transplants without immunosuppression.
    Brooks-Worrell BM; Peterson KP; Peterson CM; Palmer JP; Jovanovic L
    Transplantation; 2000 Jan; 69(1):166-72. PubMed ID: 10653397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation.
    Huurman VA; Hilbrands R; Pinkse GG; Gillard P; Duinkerken G; van de Linde P; van der Meer-Prins PM; Versteeg-van der Voort Maarschalk MF; Verbeeck K; Alizadeh BZ; Mathieu C; Gorus FK; Roelen DL; Claas FH; Keymeulen B; Pipeleers DG; Roep BO
    PLoS One; 2008 Jun; 3(6):e2435. PubMed ID: 18560516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet cell autoimmunity in type I diabetic patients after HLA-mismatched pancreas transplantation.
    Bosi E; Bottazzo GF; Secchi A; Pozza G; Shattock M; Saunders A; Gelet A; Touraine JL; Traeger J; Dubernard JM
    Diabetes; 1989 Jan; 38 Suppl 1():82-4. PubMed ID: 2642861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet transplantation in the twenty-first century.
    Thomas FT; Hutchings A; Contreras J; Wu J; Jiang XL; Eckhoff D; Thomas JM
    Immunol Res; 2002; 26(1-3):289-96. PubMed ID: 12403366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
    Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
    Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens.
    Füchtenbusch M; Kredel K; Bonifacio E; Schnell O; Ziegler AG
    Diabetes; 2000 Jun; 49(6):918-25. PubMed ID: 10866043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful [correction of Succesful] transplantation of human islets in recipients bearing a kidney graft.
    Bertuzzi F; Grohovaz F; Maffi P; Caumo A; Aldrighetti L; Nano R; Hengster P; Calori G; Di Carlo V; Bonifacio E; Secchi A
    Diabetologia; 2002 Jan; 45(1):77-84. PubMed ID: 11845226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
    Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
    Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes.
    Piemonti L; Everly MJ; Maffi P; Scavini M; Poli F; Nano R; Cardillo M; Melzi R; Mercalli A; Sordi V; Lampasona V; Espadas de Arias A; Scalamogna M; Bosi E; Bonifacio E; Secchi A; Terasaki PI
    Diabetes; 2013 May; 62(5):1656-64. PubMed ID: 23274902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Islet transplantation in type I diabetes mellitus].
    Lehmann R; Pavlicek V; Spinas GA; Weber M
    Ther Umsch; 2005 Jul; 62(7):481-6. PubMed ID: 16075955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.